Immatics N.V. (IMTXW)
Immatics Announces Third Quarter 2025 Financial Results and Business Update
BioRestorative Therapies Inc (BRTX)
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
GE HealthCare Technologies Inc (GEHC)
GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
ADC Therapeutics SA (ADCT)
Immatics Announces Third Quarter 2025 Financial Results and Business Update
Castle Biosciences Inc (CSTL)
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
EyePoint Pharmaceuticals Inc (EYPT)
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sharps Technology Inc (STSS)
Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy
Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment
BIOLINE RX (BLRX)
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
Becton Dickinson and Company (BDX)
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification